Syndax Pharmaceuticals Inc. has announced the granting of inducement awards as part of its 2023 Inducement Plan. Effective July 1, 2025, the company has provided stock options to purchase up to 228,400 shares of common stock to 14 new employees. These options will vest over a period of four years, with an initial 25% of the shares vesting on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the shares will vest monthly over the following 36 months, contingent on the employees' continued service with the company.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。